Ikeda, Japan

Toshihide Okajima

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Beacle, Inc., Japan Science and Technology Agency. Active years: 2011.



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Toshihide Okajima in Drug Delivery Systems.

Introduction

Toshihide Okajima is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of drug delivery systems, particularly through his innovative use of hollow nanoparticles. His work focuses on enhancing the effectiveness of therapeutic drugs by utilizing advanced protein nanoparticles.

Latest Patents

One of Okajima's key inventions is a patent for a hollow nanoparticle of NBsAg large protein for drug delivery. This invention provides a therapeutic drug that employs hollow protein nanoparticles displaying an antibody against specific cells or tissues. The effectiveness of this drug has been validated through animal testing. The invention also outlines a therapeutic method that utilizes such a drug. In this innovative drug, a substance intended for cellular transfer, such as a cancer-treating gene derived from the simple herpes virus, is encapsulated within hollow nanoparticles made from a particle-forming protein. The surface of these nanoparticles displays an antibody, such as a cancer-specific antibody, which recognizes antigen molecules on the surface of specific cancer cells.

Career Highlights

Throughout his career, Toshihide Okajima has worked with esteemed organizations, including the Japan Science and Technology Agency and Beacle, Inc. His work has been instrumental in advancing the field of drug delivery, particularly in targeting cancer cells effectively.

Collaborations

Okajima has collaborated with notable colleagues such as Shunichi Kuroda and Katsuyuki Tanizawa. These collaborations have further enriched his research and innovations in the field.

Conclusion

Toshihide Okajima's contributions to drug delivery systems through his innovative use of hollow nanoparticles represent a significant advancement in therapeutic methods. His work continues to influence the development of targeted cancer treatments, showcasing the potential of his inventions in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…